{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T07:19:26Z","timestamp":1769757566898,"version":"3.49.0"},"reference-count":19,"publisher":"Oncology Nursing Society (ONS)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CJON"],"published-print":{"date-parts":[[2020,2,1]]},"DOI":"10.1188\/20.cjon.19-21","type":"journal-article","created":{"date-parts":[[2020,1,21]],"date-time":"2020-01-21T13:00:33Z","timestamp":1579611633000},"page":"19-21","source":"Crossref","is-referenced-by-count":4,"title":["Liquid Biopsy: A Tool for the Diagnostic and Prognostic Evaluation of Cancers"],"prefix":"10.1188","volume":"24","author":[{"given":"Joshua","family":"Stanciu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Tariman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1302","published-online":{"date-parts":[[2020,2,1]]},"reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Arneth, B. (2018). Update on the types and usage of liquid biopsies in the clinical setting: A systematic review. BMC Cancer, 18, 527. https:\/\/doi.org\/10.1186\/s12885-018-4433-3","DOI":"10.1186\/s12885-018-4433-3"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Carr, E., & Rosato, E.M. (2019). Making the case: Clinical assessment of financial toxicity. Clinical Journal of Oncology Nursing, 23(Suppl. 2), 19\u201326. https:\/\/doi.org\/10.1188\/19.CJON.S2.19-26","DOI":"10.1188\/19.CJON.S2.19-26"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Coco, S., Alama, A., Vanni, I., Fontana, V., Genova, C., Dal Bello, M.G., . . . Grossi, F. (2017). Circulating cell-free DNA and circulating tumor cells as prognostic and predictive biomarkers in advanced non-small cell lung cancer patients treated with first-line chemotherapy. International Journal of Molecular Sciences, 18, 1035. https:\/\/doi.org\/10.3390\/ijms18051035","DOI":"10.3390\/ijms18051035"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Finotti, A., Allegretti, M., Gasparello, J., Giacomini, P., Spandidos, D.A., Spoto, G., & Gambari, R. (2018). Liquid biopsy and PCR-free ultrasensitive detection systems in oncology (review). International Journal of Oncology, 53, 1395\u20131434. https:\/\/doi.org\/10.3892\/ijo.2018.4516","DOI":"10.3892\/ijo.2018.4516"},{"key":"5","unstructured":"Foundation Medicine, Inc. (n.d.). FoundationOne\u00ae Liquid. Retrieved from https:\/\/bit.ly\/2Fviqnz"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Hofman, P. (2017). Liquid biopsy and therapeutic targets: Present and future issues in thoracic oncology. Cancers, 9, 154. https:\/\/doi.org\/10.3390\/cancers9110154","DOI":"10.3390\/cancers9110154"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Horowitz, C.R., Sabin, T., Ramos, M., Richardson, L.D., Hauser, D., Robinson, M., & Fei, K. (2019). Successful recruitment and retention of diverse participants in a genomics clinical trial: A good invitation to a great party. Genetics in Medicine, 21, 2364\u20132370. https:\/\/doi.org\/10.1038\/s41436-019-0498-x","DOI":"10.1038\/s41436-019-0498-x"},{"key":"8","unstructured":"Knight, S.B., Crosbie, P.A., Balata, H., Chudziak, J., Hussell, T., & Dive, C. (2017). Progress and prospects of early detection in lung cancer. Open Biology, 7, 170070."},{"key":"9","doi-asserted-by":"crossref","unstructured":"Lim, M., Kim, C.-J., Sunkara, V., Kim, M.-H., & Cho, Y.-K. (2018). Liquid biopsy in lung cancer: Clinical applications of circulating biomarkers (CTCs and ctDNA). Micromachines, 9, 100. https:\/\/doi.org\/10.3390\/mi9030100","DOI":"10.3390\/mi9030100"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Mader, S., & Pantel, K. (2017). Liquid biopsy: Current status and future perspectives. Oncology Research and Treatment, 40, 404\u2013408. https:\/\/doi.org\/10.1159\/000478018","DOI":"10.1159\/000478018"},{"key":"11","unstructured":"National Cancer Institute. (n.d.-a). Liquid biopsy\u2014A new, noninvasive technique that can detect disease biomarkers in the blood, urine, and sputum. Retrieved from https:\/\/bit.ly\/35rEqdu"},{"key":"12","unstructured":"National Cancer Institute. (n.d.-b). Liquid Biopsy Consortium. Retrieved from https:\/\/bit.ly\/37KSY9O"},{"key":"13","unstructured":"National Cancer Institute. (n.d.-c). Organizations that offer cancer support services. Retrieved from https:\/\/bit.ly\/2T1TYlu"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Scarlotta, M., Simsek, C., & Kim, A.K. (2019). Liquid biopsy in solid malignancy. Genetic Testing and Molecular Biomarkers, 23, 284\u2013296. https:\/\/doi.org\/10.1089\/gtmb.2018.0237","DOI":"10.1089\/gtmb.2018.0237"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Tariman, J.D., Doorenbos, A., Schepp, K.G., Singhal, S., & Berry, D.L. (2014). Information needs priorities in patients diagnosed with cancer: A systematic review. Journal of the Advanced Practitioner in Oncology, 5, 115\u2013122. https:\/\/doi.org\/10.6004\/jadpro.2014.5.2.10","DOI":"10.6004\/jadpro.2014.5.2.10"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Thomas, T., Hughes, T., Mady, L.J., & Belcher, S.M. (2019). Financial toxicity: A review of the literature and nursing opportunities. Clinical Journal of Oncology Nursing, 23(Suppl. 2), 5\u201313. https:\/\/doi.org\/10.1188\/19.CJON.S2.5-13","DOI":"10.1188\/19.CJON.S2.5-13"},{"key":"17","unstructured":"U.S. National Library of Medicine. (2016). Biomarkers, tumor. Retrieved from https:\/\/bit.ly\/37H5x5R"},{"key":"18","unstructured":"U.S. National Library of Medicine. (2018). Liquid biopsy. Retrieved from https:\/\/bit.ly\/2Quf7Dj"},{"key":"19","unstructured":"U.S. National Library of Medicine. (2020). What is the Precision Medicine Initiative? Retrieved from https:\/\/bit.ly\/2R71RUv"}],"container-title":["Clinical Journal of Oncology Nursing"],"original-title":[],"link":[{"URL":"http:\/\/cjon.ons.org\/cjon\/24\/1\/liquid-biopsy-tool-diagnostic-and-prognostic-evaluation-cancers","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T19:50:31Z","timestamp":1763754631000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ons.org\/publications-research\/cjon\/24\/1\/liquid-biopsy-tool-diagnostic-and-prognostic-evaluation-cancers"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,1]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2,1]]}},"URL":"https:\/\/doi.org\/10.1188\/20.cjon.19-21","relation":{},"ISSN":["1092-1095","1538-067X"],"issn-type":[{"value":"1092-1095","type":"print"},{"value":"1538-067X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,1]]}}}